Importance of Preclinical Studies in the Development of Drugs for Treatment of Osteoporosis: A Review Related to the 1998 WHO Guidelines J.-P. BonjourP. AmmannR. Rizzoli Review Article Pages: 379 - 393
An International Comparison of Serum 25-Hydroxyvitamin D Measurements P. LipsM. C. ChapuyM. F. Holick Original Article Pages: 394 - 397
The Role of Serum TGF-β Isoforms as Potential Markers of Osteoporosis D. J. GraingerJ. PercivalT. D. Spector Original Article Pages: 398 - 404
The Relationships Between the Degree of β-Isomerization of Type I Collagen Degradation Products in the Urine and Aging, Menopause and Osteoporosis with Fractures H. HoshinoM. TakahashiT. Inoue Original Article Pages: 405 - 409
Image Analysis of the Distal Radius Trabecular Network Using Computed Tomography B. CortetP. DuboisX. Marchandise Original Article Pages: 410 - 419
Vertebral Bone Mineral Density, Content and Area in 8789 Normal Women Aged 33–73 Years Who Have Never Had Hormone Replacement Therapy A. J. ShipmanG. W. G. GuyR. Smith Original Article Pages: 420 - 426
Bone Density Measurements by Computed Tomography in Osteogenesis Imperfecta Type I M. E. MillerT. N. Hangartner Original Article Pages: 427 - 432
Relationship Between Structural Parameters, Bone Mineral Density and Fracture Load in Lumbar Vertebrae, Based on High-Resolution Computed Tomography, Quantitative Computed Tomography and Compression Tests M. A. HaidekkerR. AndresenH. J. Werner Original Article Pages: 433 - 440
Changes in Bone Density after Exposure to Oral Anticoagulants: A Meta-analysis P. J. CaraballoS. E. GabrielL. J. Melton III Original Article Pages: 441 - 448
Effects of Age, Menopause and Osteoporosis on Free, Peptide-Bound and Total Pyridinium Crosslink Excretion M. T. Del CampoM. L. González-CasausM. E. Martínez Original Article Pages: 449 - 454
Skeletal Benefits of Two Years of Alendronate Treatment Are Similar for Early Postmenopausal Asian and Caucasian Women R. D. WasnichP. D. RossA. J. Yates Original Article Pages: 455 - 460
Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study H. A. P. PolsD. Felsenbergfor the Fosamax® International Trial Study Group Original Article Pages: 461 - 468